Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03052569
Title Expanded Access to RXDX-105 for Cancers With RET Alterations
Recruitment No longer available
Gender both
Phase Expanded access
Variant Requirements Yes
Sponsors Ignyta, Inc.
Indications

Advanced Solid Tumor

Therapies

RXDX-105

Age Groups: adult | child | senior
Covered Countries USA

Additional content available in CKB BOOST